The nhlbi requires the gene therapy resource program (gtrp) support translational gene therapy research by providing resources and services from four core laboratories: 1.) pharmacology and toxicology…
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N92019D00017
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 7 $4,413,813 obligated
Award facts
- Opportunity
-
- Gene Therapy Resource Program (GTRP) Pre-Solicitation · HHSN26818HV00005R · Posted Sep 19, 2017
- Gene Therapy Resource Program (GTRP) Award Notice · Posted Dec 21, 2018
- Combined order value
- $4,413,813 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 33% used
- $13,300,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $13.3M contract, titled the "Gene Therapy Resource Program (GTRP)," aims to support translational gene therapy research by providing resources and services from three core laboratories: Pharmacology and Toxicology, Preclinical Vector, and a Clinical Coordinating Center.
The contract has a total period of performance through June 18, 2025 and does not utilize any set-aside designations. Multiple task orders have been issued to Lovelace Biomedical, valued at over $4.6M cumulatively, for specific GTRP support services such as pharmacology/toxicology studies, scientific project support, and core administrative activities. Lovelace Biomedical has a proven track record as a prime contractor for federal agencies like NIH, DoD, and HHS, providing a wide range of preclinical research services including animal studies, analytical testing, and disease model development.
Description
The nhlbi requires the gene therapy resource program (gtrp) support translational gene therapy research by providing resources and services from four core laboratories: 1.) pharmacology and toxicology core laboratory, 2.) preclinical vector core laboratory, 3.) clinical coordinating center (CCC), which is not required to have any laboratory capabilities.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N92019D00017?
75N92019D00017 was awarded to Lovelace Biomedical Research Institute by National Heart Lung and Blood Institute (National Institutes of Health) on December 19, 2018.
How much is contract 75N92019D00017 worth?
Orders under 75N92019D00017 have obligated $4,413,813. 75N92019D00017's own ceiling is $13,300,000.
How many orders have been placed under contract 75N92019D00017?
7 orders have been placed under 75N92019D00017, the latest on December 19, 2023.
Who can order from contract 75N92019D00017?
75N92019D00017 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N92019D00017 competed?
The extent of competition for 75N92019D00017 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV